310 related articles for article (PubMed ID: 14709936)
21. Some clarity in the management of DCIS in breast cancer screening.
Wald NJ
J Med Screen; 2011; 18(3):112. PubMed ID: 22045817
[No Abstract] [Full Text] [Related]
22. Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ.
Elshof LE; Schmidt MK; Rutgers EJT; van Leeuwen FE; Wesseling J; Schaapveld M
Ann Surg; 2018 May; 267(5):952-958. PubMed ID: 28375855
[TBL] [Abstract][Full Text] [Related]
23. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
24. Actual management of ductal carcinoma in situ of the breast.
Maass N; Alkasi O; Bauer M; Jonat W; Souchon R; Meinhold-Heerlein I
Arch Gynecol Obstet; 2009 Nov; 280(5):699-705. PubMed ID: 19259692
[TBL] [Abstract][Full Text] [Related]
25. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?
Punglia RS; Schnitt SJ; Weeks JC
J Natl Cancer Inst; 2013 Oct; 105(20):1527-33. PubMed ID: 24068769
[TBL] [Abstract][Full Text] [Related]
26. The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast.
Villanueva H; Grimm S; Dhamne S; Rajapakshe K; Visbal A; Davis CM; Ehli EA; Hartig SM; Coarfa C; Edwards DP
J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):237-248. PubMed ID: 30338425
[TBL] [Abstract][Full Text] [Related]
27. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
28. Ductal carcinoma in situ: morphology-based knowledge and molecular advances.
Ross DS; Wen YH; Brogi E
Adv Anat Pathol; 2013 Jul; 20(4):205-16. PubMed ID: 23752083
[TBL] [Abstract][Full Text] [Related]
29. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Sakorafas GH; Tsiotou AG
Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
[TBL] [Abstract][Full Text] [Related]
30. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.
de Mascarel I; MacGrogan G; Mathoulin-Pélissier S; Soubeyran I; Picot V; Coindre JM
Cancer; 2002 Apr; 94(8):2134-42. PubMed ID: 12001109
[TBL] [Abstract][Full Text] [Related]
31. Paget's disease of the nipple with parenchymal ductal carcinoma in situ is associated with worse prognosis than Paget's disease alone.
Durkan B; Bresee C; Bose S; Phillips EH; Dang CM
Am Surg; 2013 Oct; 79(10):1009-12. PubMed ID: 24160789
[TBL] [Abstract][Full Text] [Related]
32. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Rudloff U; Brogi E; Brockway JP; Goldberg JI; Cranor M; Wynveen CA; Nehhozina T; Reiner AS; Patil S; Van Zee KJ
Cancer; 2009 Mar; 115(6):1203-14. PubMed ID: 19170233
[TBL] [Abstract][Full Text] [Related]
33. Biology of ductal carcinoma in situ classification based on biologic potential.
Tsikitis VL; Chung MA
Am J Clin Oncol; 2006 Jun; 29(3):305-10. PubMed ID: 16755185
[TBL] [Abstract][Full Text] [Related]
34. Conservative management of intraductal carcinoma (DCIS) of the breast. Collaborating NSABP investigators.
Fisher ER; Leeming R; Anderson S; Redmond C; Fisher B
J Surg Oncol; 1991 Jul; 47(3):139-47. PubMed ID: 1649353
[TBL] [Abstract][Full Text] [Related]
35. Non-invasive breast carcinoma.
Posner MC; Wolmark N
Breast Cancer Res Treat; 1992; 21(3):155-64. PubMed ID: 1325215
[TBL] [Abstract][Full Text] [Related]
36. Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia.
Knudsen ES; Ertel A; Davicioni E; Kline J; Schwartz GF; Witkiewicz AK
Breast Cancer Res Treat; 2012 Jun; 133(3):1009-24. PubMed ID: 22134623
[TBL] [Abstract][Full Text] [Related]
37. [Does molecular biology play any role in ductal carcinoma in situ?].
Sakr RA
Gynecol Obstet Fertil; 2013 Jan; 41(1):45-53. PubMed ID: 23286959
[TBL] [Abstract][Full Text] [Related]
38. Li-Fraumeni syndrome: a case report and discussion.
Hendry P; Whitford P
Scott Med J; 2005 Aug; 50(3):130-1. PubMed ID: 16164004
[TBL] [Abstract][Full Text] [Related]
39. A comparison of two models for breast cancer mortality for women with ductal carcinoma in situ: an SEER-based analysis.
Giannakeas V; Sopik V; Narod SA
Breast Cancer Res Treat; 2018 Jun; 169(3):587-594. PubMed ID: 29445939
[TBL] [Abstract][Full Text] [Related]
40. Twenty-year outcomes after breast-conserving surgery and definitive radiotherapy for mammographically detected ductal carcinoma in situ.
Wilkinson JB; Vicini FA; Shah C; Shaitelman S; Jawad MS; Ye H; Kestin LL; Goldstein NS; Martinez AA; Benitez P; Chen PY
Ann Surg Oncol; 2012 Nov; 19(12):3785-91. PubMed ID: 22644510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
